DE3405172C2 - - Google Patents

Info

Publication number
DE3405172C2
DE3405172C2 DE3405172A DE3405172A DE3405172C2 DE 3405172 C2 DE3405172 C2 DE 3405172C2 DE 3405172 A DE3405172 A DE 3405172A DE 3405172 A DE3405172 A DE 3405172A DE 3405172 C2 DE3405172 C2 DE 3405172C2
Authority
DE
Germany
Prior art keywords
salt
erythromycin
thiazolidin
acid
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3405172A
Other languages
German (de)
English (en)
Other versions
DE3405172A1 (de
Inventor
Camillo Corvi Piacenza It Mora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CAMILLO CORVI SpA MAILAND/MILANO IT
Original Assignee
CAMILLO CORVI SpA MAILAND/MILANO IT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CAMILLO CORVI SpA MAILAND/MILANO IT filed Critical CAMILLO CORVI SpA MAILAND/MILANO IT
Publication of DE3405172A1 publication Critical patent/DE3405172A1/de
Application granted granted Critical
Publication of DE3405172C2 publication Critical patent/DE3405172C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DE3405172A 1983-02-16 1984-02-14 Erythromycinsalz der 2-(1,3-thiazolidin-3-yl)carbonylbenzoesaeure, verfahren zu seiner herstellung und es enthaltende pharmazeutische zusammensetzungen Granted DE3405172A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19621/83A IT1163108B (it) 1983-02-16 1983-02-16 Sale di eritromicina dell'acido benzoico-o-carboniltiazolidina,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono

Publications (2)

Publication Number Publication Date
DE3405172A1 DE3405172A1 (de) 1984-08-16
DE3405172C2 true DE3405172C2 (US06653308-20031125-C00197.png) 1987-10-08

Family

ID=11159745

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3405172A Granted DE3405172A1 (de) 1983-02-16 1984-02-14 Erythromycinsalz der 2-(1,3-thiazolidin-3-yl)carbonylbenzoesaeure, verfahren zu seiner herstellung und es enthaltende pharmazeutische zusammensetzungen

Country Status (6)

Country Link
US (1) US4575496A (US06653308-20031125-C00197.png)
JP (1) JPS59161365A (US06653308-20031125-C00197.png)
DE (1) DE3405172A1 (US06653308-20031125-C00197.png)
FR (1) FR2540876B1 (US06653308-20031125-C00197.png)
GB (1) GB2135308B (US06653308-20031125-C00197.png)
IT (1) IT1163108B (US06653308-20031125-C00197.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133925A1 (en) * 2001-09-28 2003-07-17 Shawar Ribhi M. Monobactam compositions and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE766293A (en) * 1971-04-26 1971-09-16 Dechamps Pierre Antimicrobial erythromycin benzoate
US4264765A (en) * 1980-02-20 1981-04-28 Abbott Laboratories Salts of erythromycin A esters
FR2502627A1 (fr) * 1981-02-02 1982-10-01 Refarmed Sa Derives thioliques de l'erythromycine a activite therapeutique, procede de preparation et produits pharmaceutiques dans lesquels ils apparaissent
US4396613A (en) * 1981-12-14 1983-08-02 Eli Lilly And Company 23-Ester derivatives of DMT and method of using same

Also Published As

Publication number Publication date
IT1163108B (it) 1987-04-08
DE3405172A1 (de) 1984-08-16
FR2540876B1 (fr) 1987-05-22
GB2135308A (en) 1984-08-30
JPS59161365A (ja) 1984-09-12
FR2540876A1 (fr) 1984-08-17
US4575496A (en) 1986-03-11
IT8319621A0 (it) 1983-02-16
GB2135308B (en) 1986-08-13
GB8403886D0 (en) 1984-03-21
JPH0374219B2 (US06653308-20031125-C00197.png) 1991-11-26

Similar Documents

Publication Publication Date Title
DE3005164C2 (de) 1,1-Dioxopenicillanoyloxymethyl-6-(D-α-amino-α-phenylacetamido)-penicillanat, Verfahren zu seiner Herstellung und es enthaltendes Arzneimittel
DE1445154B2 (de) 1,4-dihydro-1,8-naphthyridinderivate und ein verfahren zu ihrer herstellung
DE2819479C2 (US06653308-20031125-C00197.png)
DE2409654A1 (de) Therapeutisches mittel
DE2502916C2 (US06653308-20031125-C00197.png)
DE2641388C3 (de) 3',4'-Didesoxykanamycin B-N-methansulfonsäuren und deren Alkalimetallsalze sowie diese Verbindungen enthaltende pharmazeutische Präparate
DE3780382T2 (de) Metall komplexe von n-methyl-11-aza-10-deoxy-10-dihydroerythromycin-a oder von 11-aza-10-deoxy-10-dihydroxyerythromycin-a, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von pharmazeutischen praeparaten.
DE2509260C3 (de) a-(23,43,6-Penta-O-acetyl-D-gluconyl-thioureido)benzylpenicillin
DE2301540A1 (de) 5-0-(5-amino-5-deoxy-d-pentofuranosyl)n hoch 1-(4-amino-2-hydroxy-butyryl)-4-0(2,6-diamino-2,6-dideoxy-d-gluco-pyranosyl)2-deoxystreptamine
DE3405172C2 (US06653308-20031125-C00197.png)
DE3133215C2 (de) N-Methansulfonsäurederivate von Istamycin A oder B, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3139554C2 (US06653308-20031125-C00197.png)
DE3302699C2 (de) N-Methansulfonsäure-Derivate von 3-0-Desmethylistamycin B, Verfahren zu ihrer Herstellung und solche Derivate enthaltende pharmazeutische Mittel
DE69307894T2 (de) Ng-monomethyl-l-arginin-hydrochlorid-derivate und verfahren zu deren herstellung
DE2203653B2 (de) 3-Carbamoyloxymethyl-7-(2-thienylacetamido)-3-cephem-4-carbonsäure und deren Salze, Verfahren zur Herstellung dieser Verbindungen und solche Verbindungen enthaltende Arzneimittel
DE3121175A1 (de) Erythro-1,2,3-triphenyl-1-pentanon-derivate sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3310584C2 (US06653308-20031125-C00197.png)
DE2512587C3 (de) 1 -N-(L-4-Amino-2-hydroxybutyryl)-6' -N-alkylkanamycine A, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
DE2741431C3 (de) l-N-(L-4-Amino-2-hydroxybutyryl)-3'-desoxykanamycin-C, l-N-(L-4-Amino-2hydroxybutyryl)-3',4'-didesoxykanamycin-C und deren Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende antibakterielle Zusammensetzungen
DE3024304C2 (US06653308-20031125-C00197.png)
DE2154027C3 (de) alpha- (N-2-Pyrimidylf ormamidlno) benzylpenicillin sowie dessen nichttoxische Salze, Verfahren zu seiner Herstellung sowie es enthaltende Arzneimittel
DE1941036C (de) Tetracyclinlaktat
AT220146B (de) Verfahren zur Herstellung des neuen Betainsalicylats
DE2115281A1 (de) 4-Hydroxy- l-phenyl-2-pyrrolidino-pentan, dessen Diastereomere und Salze und Verfahren zur Herstellung
DE1793176C2 (de) 6-Epi-6-desoxy-tetracyclin, 6-Epi-6desoxy-5-oxytetracyclin, deren pharmakologisch brauchbaren Säureadditionssalze und Metallsalze sowie diese Verbindungen enthaltende Antibiotika

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: TUERK, D., DIPL.-CHEM. DR.RER.NAT. GILLE, C., DIPL

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee